国际医药卫生导报2010，Vol.16Issue(5)：577-579,3.DOI:10.3760/cma.j.issn.1007-1245.2010.05.026
新生儿肺炎克雷伯菌肺炎药敏分析
Study on drug resistance newborn of klebsiella pneumoniae
刘紫菱 1邓文喻 1赖卫明 1穆小萍 1黄宗杰1
作者信息
- 1. 510010,广州,广东省妇幼保健院检验科
- 折叠
摘要
Abstract
Objective To probe into the drug sensitivity about newborn pneumonia of Klebsiella pneumoniae(Kp) and investigate the positive rate of extended-spectrum β-lactamases(ESBLs) in klebsiella pneumoniae.and provide the evidence of reasonable treatment. Method 71 cases of sputum samples new-born pneumonia ofklebsiella pneumoniae from july2008 to may2009 were collected use BioMerieux VITEK2 Compact to Bacteria identification and drug sensitivity testwere per-formed. At the same time, ESBLs were detected. Results the positive rate of ESBLs in klebsiella pneumoniae was 71.8 %, Kp was 100% sensitive to carbopenems, e.g lmipenen, Meropenen, and 80%～90% to Amikacin and Ciprofloxacin,which were hardly used in newborn recent years. While it was resistant to commonly used Penicillin and Cephalosporin.. ESBLs negative strains had higher drug sensitivity than ESBLs strain.Conclusions Partial klebsiella pneumoniae are ESBLs strains and insensitive to commonly used antibiotics. In order to decrease ESBLs strains, the antibiotics treatment shall be used appropriately and the selection of antibiotics shallbe guided by the results ofdrug sensitivity tests.关键词
肺炎/肺炎克雷伯菌/新生儿/超广谱β-内酰胺酶Key words
Newborn/Pneumonia/Klebsiella pneumoniae/ESBLs引用本文复制引用
刘紫菱,邓文喻,赖卫明,穆小萍,黄宗杰..新生儿肺炎克雷伯菌肺炎药敏分析[J].国际医药卫生导报,2010,16(5):577-579,3.
